Solid‐type poorly differentiated adenocarcinoma of the stomach: Deficiency of mismatch repair and SWI/SNF complex

ARID1A, one of the subunits in SWI/SNF chromatin remodeling complex, is frequently mutated in gastric cancers with microsatellite instability (MSI). The most frequent MSI in solid‐type poorly differentiated adenocarcinoma (PDA) has been reported, but the SWI/SNF complex status in solid‐type PDA is still largely unknown. We retrospectively analyzed 54 cases of solid‐type PDA for the expressions of mismatch repair (MMR) proteins (MLH1, PMS2, MSH2, and MSH6), SWI/SNF complex subunits (ARID1A, INI1, BRG1, BRM, BAF155, and BAF170) and EBER, and mutations in KRAS and BRAF. We analyzed 40 cases of another histological type of gastric cancer as a control group. The solid‐type PDAs showed coexisting glandular components (76%), MMR deficiency (39%), and complete/partial loss of ARID1A (31%/7%), INI1 (4%/4%), BRG1 (48%/30%), BRM (33%/33%), BAF155 (13%/41%), and BAF170 (6%/2%), EBER positivity (4%), KRAS mutation (2%), and BRAF mutation (2%). Compared to the control group, MMR deficiency and losses of ARID1A, BRG1, BRM, and BAF155 were significantly frequent in solid‐type PDAs. Mismatch repair deficiency was associated with the losses of ARID1A, BRG1, and BAF155 in solid‐type PDAs. In the MMR‐deficient group, solid components showed significantly more frequent losses of ARID1A, BRG1, BRM, and BAF155 compared to glandular components (P = .0268, P = .0181, P = .0224, and P = .0071, respectively). In the MMR‐proficient group, solid components showed significantly more frequent loss of BRG1 compared to glandular components (P = .012). In conclusion, solid‐type PDAs showed frequent losses of MMR proteins and the SWI/SNF complex. We suggest that loss of the SWI/SNF complex could induce a morphological shift from differentiated‐type adenocarcinoma to solid‐type PDA.

[1]  T. Yamanaka,et al.  Utility of the quasi‐monomorphic variation range in unresectable metastatic colorectal cancer patients , 2018, Cancer science.

[2]  T. Ishiwata,et al.  Solid-type poorly differentiated adenocarcinoma of the stomach: clinicopathological and molecular characteristics and histogenesis , 2018, Gastric Cancer.

[3]  K. Washington,et al.  Gastric Carcinomas With Lymphoid Stroma: Categorization and Comparison With Solid-Type Colonic Carcinomas , 2017, American journal of clinical pathology.

[4]  Y. Oda,et al.  Oncogenic roles of SMARCB1/INI1 and its deficient tumors , 2017, Cancer science.

[5]  S. Cascinu,et al.  The evolving role of microsatellite instability in colorectal cancer: A review. , 2016, Cancer treatment reviews.

[6]  K. Devarajan,et al.  Immunohistochemistry Successfully Uncovers Intratumoral Heterogeneity and Widespread Co-Losses of Chromatin Regulators in Clear Cell Renal Cell Carcinoma , 2016, PloS one.

[7]  C. Toon,et al.  Loss of INI1 expression in colorectal carcinoma is associated with high tumor grade, poor survival, BRAFV600E mutation, and mismatch repair deficiency. , 2016, Human pathology.

[8]  J. Pyo,et al.  Medullary carcinoma in the colorectum: a systematic review and meta-analysis. , 2016, Human pathology.

[9]  A. Gill,et al.  Medullary carcinoma of the colon: a distinct morphology reveals a distinctive immunoregulatory microenvironment , 2016, Modern Pathology.

[10]  H. Kijima,et al.  Clinicopathological significance of gastric poorly differentiated medullary carcinoma. , 2016, Biomedical research.

[11]  Dakeun Lee,et al.  Various ARID1A expression patterns and their clinical significance in gastric cancers. , 2016, Human pathology.

[12]  Y. Maehara,et al.  Expression of adhesion molecules and epithelial-mesenchymal transition factors in medullary carcinoma of the colorectum. , 2015, Human pathology.

[13]  Sin-Ho Jung,et al.  Lymphoepithelioma-like carcinoma: a distinct type of gastric cancer. , 2015, The Journal of surgical research.

[14]  M. Fukayama,et al.  Profiling of Virus-Encoded MicroRNAs in Epstein-Barr Virus-Associated Gastric Carcinoma and Their Roles in Gastric Carcinogenesis , 2015, Journal of Virology.

[15]  K. Kuo,et al.  Ovarian and endometrial endometrioid adenocarcinomas have distinct profiles of microsatellite instability, PTEN expression, and ARID1A expression , 2015, Histopathology.

[16]  C. Toon,et al.  Medullary Colorectal Carcinoma Revisited: A Clinical and Pathological Study of 102 Cases , 2015, Annals of Surgical Oncology.

[17]  M. Gönen,et al.  Immunohistochemical detection of ARID1A in colorectal carcinoma: loss of staining is associated with sporadic microsatellite unstable tumors with medullary histology and high TNM stage. , 2014, Human pathology.

[18]  M. Yaniv Chromatin remodeling: from transcription to cancer. , 2014, Cancer genetics.

[19]  A. Chou,et al.  Loss of ARID1A expression in colorectal carcinoma is strongly associated with mismatch repair deficiency. , 2014, Human pathology.

[20]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of gastric adenocarcinoma , 2014, Nature.

[21]  F. Liu,et al.  Reduced expression of the chromatin remodeling gene ARID1A enhances gastric cancer cell migration and invasion via downregulation of E-cadherin transcription. , 2014, Carcinogenesis.

[22]  M. Sawabe,et al.  Frequent microsatellite instability in papillary and solid-type, poorly differentiated adenocarcinomas of the stomach , 2013, Gastric Cancer.

[23]  M. Ribeiro,et al.  MGMT and MLH1 methylation in Helicobacter pylori-infected children and adults. , 2013, World journal of gastroenterology.

[24]  Y. Miyagi,et al.  KRAS and BRAF mutations are rare and related to DNA mismatch repair deficiency in gastric cancer from the East and the West: Results from a large international multicentre study , 2013, British Journal of Cancer.

[25]  S. Ishikawa,et al.  Lung cancer with loss of BRG1/BRM, shows epithelial mesenchymal transition phenotype and distinct histologic and genetic features , 2013, Cancer science.

[26]  S. Ishikawa,et al.  ARID1A expression loss in gastric cancer: pathway-dependent roles with and without Epstein–Barr virus infection and microsatellite instability , 2012, Virchows Archiv.

[27]  Zhengyan Kan,et al.  Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer , 2011, Nature Genetics.

[28]  K. Chayama,et al.  Low Prevalence of Helicobacter pylori‐negative Gastric Cancer among Japanese , 2011, Helicobacter.

[29]  Meng Li,et al.  Somatic Mutations in the Chromatin Remodeling Gene ARID1A Occur in Several Tumor Types , 2011, Human mutation.

[30]  C. Roberts,et al.  SWI/SNF nucleosome remodellers and cancer , 2011, Nature Reviews Cancer.

[31]  F. Roviello,et al.  Oncogenic mutations in gastric cancer with microsatellite instability. , 2011, European journal of cancer.

[32]  Y. Oda,et al.  Sessile Serrated Adenoma With Early Neoplastic Progression: A Clinicopathologic and Molecular Study , 2011, The American journal of surgical pathology.

[33]  S. Sukumar*,et al.  Medullary carcinoma of the large intestine: a population based analysis. , 2010, International journal of oncology.

[34]  Shuji Fujita,et al.  Frequent loss of Brm expression in gastric cancer correlates with histologic features and differentiation state. , 2007, Cancer research.

[35]  T. Sugai,et al.  Clinicopathological significance of loss of heterozygosity in intestinal- and solid-type gastric carcinomas: a comprehensive study using the crypt isolation technique , 2006, Modern Pathology.

[36]  R. Cerutti,et al.  Intratumour T cells, their activation status and survival in gastric carcinomas characterised for microsatellite instability and Epstein–Barr virus infection , 2006, Virchows Archiv.

[37]  M. Yaniv,et al.  SWI/SNF chromatin-remodeling factors induce changes in DNA methylation to promote transcriptional activation. , 2005, Cancer research.

[38]  N. Ikehara,et al.  BRAF/K-ras mutation, microsatellite instability, and promoter hypermethylation of hMLH1/MGMT in human gastric carcinomas , 2004, Gastric Cancer.

[39]  M. Lai,et al.  Gastric medullary carcinoma, a distinct entity associated with microsatellite instability‐H, prominent intraepithelial lymphocytes and improved prognosis , 2004, Histopathology.

[40]  D. Ichikawa,et al.  Clinicopathologic and Prognostic Characterization of Poorly Differentiated Medullary-type Gastric Adenocarcinoma , 2004, World Journal of Surgery.

[41]  Stuart H. Orkin,et al.  The SWI/SNF complex — chromatin and cancer , 2004, Nature Reviews Cancer.

[42]  T. Smyrk,et al.  Tumor‐infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma , 2001, Cancer.

[43]  J. Rüschoff,et al.  Poorly differentiated colonic adenocarcinoma, medullary type: clinical, phenotypic, and molecular characteristics. , 1997, The American journal of pathology.

[44]  Appelman Hd,et al.  Crohn's-like lymphoid reaction and colorectal carcinoma: a potential histologic prognosticator. , 1990 .

[45]  P. Laurén,et al.  THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. , 1965, Acta pathologica et microbiologica Scandinavica.

[46]  Japanese Gastric Cancer Association Japanese classification of gastric carcinoma: 3rd English edition , 2011, Gastric Cancer.

[47]  H. Shimada,et al.  Clinicopathological properties of poorly-differentiated adenocarcinoma of the stomach: comparison of solid- and non-solid-types. , 2006, Anticancer research.

[48]  胃癌研究会 Japanese classification of gastric carcinoma , 1995 .

[49]  H. Appelman,et al.  Crohn's-like lymphoid reaction and colorectal carcinoma: a potential histologic prognosticator. , 1990, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[50]  W J Macdonald,et al.  GASTRIC CARCINOMA. , 1912, Canadian Medical Association journal.